ResultsIQ

ResultsIQ › Latest results › Punjab Chemicals & Crop Protection Limited

Punjab Chemicals & Crop Protection Limited Q2 FY27 results deck summary

NSE: PUNJABCHEM · BSE: 506618

Results deck of 4 Nov 2026, summarised by AI from the filing.

Q2 FY27 revenue rose 28.0% YoY to ₹326.7 cr on domestic sales, while PAT fell to ₹13.5 cr from ₹18.5 cr.

Key takeaways

  1. Q2 revenue Revenue ₹326.7 cr in Q2 FY27 (Q2 FY26: ₹255.2 cr, 28.0% YoY), driven by domestic sales.
  2. Volume guidance Management expects 100% volume growth in the current financial year for new agro intermediates.
  3. New products New products contributed 19% of Q2 FY27 revenue, growing 295% YoY.
  4. Margin pressure Q2 FY27 EBITDA margin declined to 9.0% from 10.3% a year earlier.

Original filing on BSE

Punjab Chemicals & Crop Protection Limited Q2 FY27 results

As filed: Revenue ₹327 cr (+28% year on year), EBITDA ₹29.6 cr (+9% year on year), PAT ₹13.5 cr (−29% year on year), EBITDA margin 9.0% (−154 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹347 cr (+9% year on year), EBITDA ₹40.8 cr (+17% year on year), PAT ₹22.1 cr (+5% year on year), EBITDA margin 11.8% (+82 bps). Score 60 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was below it. EBITDA margin rose 82 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −6.5% in 28 days (Nifty 500: +0.7%).
  • Q4 FY26: Revenue ₹209 cr (+3% year on year), EBITDA ₹27.5 cr (+6% year on year), PAT ₹11.0 cr (+57% year on year), EBITDA margin 13.2% (+32 bps). Score 50 of 100, In line with trend. Revenue, EBITDA and profit growth were in line with the company's own trend. EBITDA margin rose 32 bps year on year. Revenue fell 15% from last quarter. Share price after the results: −12.2% in 28 days (Nifty 500: −0.1%).
  • Q3 FY26: Revenue ₹247 cr (+15% year on year), EBITDA ₹29.6 cr (+56% year on year), PAT ₹13.8 cr (+159% year on year), EBITDA margin 12.0% (+311 bps). Score 76 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit before exceptional items growth were well above it. EBITDA margin rose 311 bps year on year. Revenue fell 3% from last quarter. Share price after the results: +17.5% in 30 days (Nifty 500: +1.5%).
  • Q2 FY26: Revenue ₹255 cr (+5% year on year), EBITDA ₹27.0 cr (+4% year on year), PAT ₹19.0 cr (+58% year on year), EBITDA margin 10.6% (−16 bps). Score 49 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 16 bps year on year. Other income 27% of PBT. Revenue fell 20% from last quarter. Share price after the results: +1.4% in 30 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹320 cr (+32% year on year), EBITDA ₹35.0 cr (+30% year on year), PAT ₹21.0 cr (+62% year on year), EBITDA margin 10.9% (−22 bps). Score 84 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were above it. EBITDA margin fell 22 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −13.7% in 29 days (Nifty 500: −0.3%).
  • Q4 FY25: Revenue ₹202 cr (+3% year on year), EBITDA ₹26.0 cr (+100% year on year), PAT ₹7.0 cr (+250% year on year), EBITDA margin 12.9% (+627 bps). Score 85 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well above it. EBITDA margin rose 627 bps year on year. Revenue fell 6% from last quarter. Share price after the results: +6.6% in 29 days (Nifty 500: +3.5%).
  • Q3 FY25: Revenue ₹214 cr (0% year on year), EBITDA ₹19.0 cr (−27% year on year), PAT ₹6.0 cr (−45% year on year), EBITDA margin 8.9% (−327 bps). Score 25 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 327 bps year on year. Revenue fell 12% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Punjab Chemicals & Crop Protection Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.